戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ations for understanding and improving colon cancer chemoprevention.
2 t retinoids are potentially useful agent for cancer chemoprevention.
3 he effectiveness of antioxidants in prostate cancer chemoprevention.
4 d xenobiotic electrophiles is a strategy for cancer chemoprevention.
5 on of curcumin as a novel approach to breast cancer chemoprevention.
6 r to take tamoxifen or raloxifene for breast cancer chemoprevention.
7  of nanotechnology to improve the outcome of cancer chemoprevention.
8 mendations on the use of 5-ARIs for prostate cancer chemoprevention.
9 a-reductase inhibitors (5-ARIs) for prostate cancer chemoprevention.
10 activating agents are in clinical trials for cancer chemoprevention.
11 vitamin E plays in photo-protection and skin cancer chemoprevention.
12 clins as molecular pharmacologic targets for cancer chemoprevention.
13 ues suggest that antioxidants may be used in cancer chemoprevention.
14  as a potential novel drug target for breast cancer chemoprevention.
15 hat fruit polyphenols have the potential for cancer chemoprevention.
16 as a candidate-pharmacologic target for lung cancer chemoprevention.
17  prevent colon cancer are recent examples of cancer chemoprevention.
18 h within the increasingly important field of cancer chemoprevention.
19 uld be placed on smoking prevention and lung cancer chemoprevention.
20 h as catechin, may play an important role in cancer chemoprevention.
21 d may define effective targets for achieving cancer chemoprevention.
22 hylated selenium metabolite is important for cancer chemoprevention.
23 2 gene expression and the roles of NSAIDs in cancer chemoprevention.
24 te their clinical potential in head and neck cancer chemoprevention.
25 on and proliferation is an important goal in cancer chemoprevention.
26 combining lovastatin with sulindac for colon cancer chemoprevention.
27 iindolylmethane (DIM) has been known to have cancer chemoprevention activity.
28 ional Cancer Institute's Phase I/II prostate cancer chemoprevention agent development program.
29                The potential for utilizing a cancer chemoprevention agent that may simultaneously red
30 could help explain its lack of efficacy as a cancer chemoprevention agent.
31 dely reported to display strong efficacy for cancer chemoprevention, although their mechanism of acti
32   Since RXRs represent important targets for cancer chemoprevention, an ultrafiltration mass spectrom
33 l usefulness of this new mouse model in lung cancer chemoprevention and chemotherapy was examined.
34  is an approved drug in the clinic for colon cancer chemoprevention and has been tested for its chemo
35 ed as potential selenium delivery agents for cancer chemoprevention and other clinical uses.
36 , PKCbetaII is an important target for colon cancer chemoprevention and the PKCbeta-selective inhibit
37 pletion may be an important novel target for cancer chemoprevention and therapy by natural and synthe
38    Retinoids have shown clinical efficacy in cancer chemoprevention and therapy presumably by modulat
39 de (4HPR), a synthetic retinoid effective in cancer chemoprevention and therapy, is thought to act vi
40           Retinoids are promising agents for cancer chemoprevention and therapy.
41 icroparticles is a promising new approach to cancer chemoprevention and therapy.
42 y of this element is a promising strategy of cancer chemoprevention and therapy.
43 ical studies and in a few clinical trials of cancer chemoprevention and therapy.
44        Vitamin D is a well-studied agent for cancer chemoprevention and treatment.
45 er tumors, suggesting a new target for liver cancer chemoprevention and/or chemotherapy.
46 epresent a dramatic impact on the history of cancer chemoprevention, and if not successful the potent
47  is the only drug approved for use in breast cancer chemoprevention, and it remains the treatment of
48 nale for using selective COX-2 inhibitors in cancer chemoprevention, and outline new avenues of resea
49 s in regulating cell death in the context of cancer chemoprevention, and present a paradigm for devel
50                        The key principles of cancer chemoprevention are discussed and areas for impro
51 on chemical carcinogenesis as an approach to cancer chemoprevention, as well as studies on the inhibi
52 y moderately effective in JMML assays and in cancer chemoprevention assays.
53                                              Cancer chemoprevention by induction of phase 2 proteins
54 ngiogenesis may be an important mechanism in cancer chemoprevention by PEITC.
55 otentially selective approach for colorectal cancer chemoprevention by targeting APC-deficient cells
56 Epidemiological data and in vitro studies on cancer chemoprevention by tea polyphenols have gained at
57 rom Se-methylselenocysteine is a key step in cancer chemoprevention by this agent.
58                                         Lung cancer chemoprevention continued to make progress in 199
59  for novel agent(s) for the armamentarium of cancer chemoprevention continues.
60 ovided information about hypothetical breast cancer chemoprevention decisions (mean uptake rate, 24.7
61 aB) is believed to play an important role in cancer chemoprevention due to its involvement in tumor c
62                    Despite great interest in cancer chemoprevention, effective agents are few.
63  class of naturally occurring compounds with cancer chemoprevention effects that have become clinical
64                                              Cancer chemoprevention has many challenges to face but t
65 r, few molecular targets for effective colon cancer chemoprevention have been characterized and valid
66  strategies to modulate polyamine levels for cancer chemoprevention in individuals at high risk of de
67 as management of biliary tract dysplasia and cancer chemoprevention in PSC.
68   We also appraise the four trials of breast-cancer chemoprevention, including the trial that has led
69  Aromatase inhibitors are established breast cancer chemoprevention interventions.
70                                     Prostate cancer chemoprevention is an alternative and potential s
71                                  Research on cancer chemoprevention is an important approach for decr
72              To maximize the benefit of lung cancer chemoprevention, it is important to identify indi
73                   In addition, the potential cancer chemoprevention of the secondary metabolites (phe
74 ures of ACF that may provide new targets for cancer chemoprevention or lead to the development of new
75 rs of these isoforms may be useful in breast cancer chemoprevention or therapy.
76 ents will hopefully streamline head and neck cancer chemoprevention research.
77 esis have led to novel molecular targets for cancer chemoprevention research.
78  impact would again be a landmark finding in cancer chemoprevention; so the time is more than ripe fo
79 helial cancers and may have implications for cancer chemoprevention strategies.
80                                           In cancer chemoprevention studies, the identification of be
81 wever, vit C has proved to be ineffective in cancer chemoprevention studies.
82   On the basis of these results, a full-term cancer chemoprevention study was conducted with DMBA-tre
83                Soy isoflavones are potential cancer chemoprevention treatments.
84 ffects of long-term retinol intake in a skin cancer chemoprevention trial in a large population at mo
85 gn and rationale of the dutasteride prostate cancer chemoprevention trial known as the REDUCE trial (
86 terventions to be utilized in the next major cancer chemoprevention trial.
87 upplements may be utilized in the next major cancer chemoprevention trial.
88 the use of a heart healthy agent in the nest cancer chemoprevention trial.
89 ouragement for the use of tazarotene in skin cancer chemoprevention trials in humans.
90 been definitive, randomized, controlled lung-cancer chemoprevention trials in the three chemopreventi
91 e of death in the largest dietary supplement cancer chemoprevention trials.
92 deration for evaluation in clinical prostate cancer chemoprevention trials.
93 the number one cause of death in the largest cancer chemoprevention trials; CVD is the number one or
94                                       Breast cancer chemoprevention uptake rates are low and variatio
95                                              Cancer chemoprevention uses natural, synthetic, or biolo
96 t PKCbetaII is an effective target for colon cancer chemoprevention using enzastaurin (LY317615), a P
97 nancy, they have started to be implicated in cancer chemoprevention, via the targeting of reversible
98 roach for detecting potential biomarkers for cancer chemoprevention was evaluated in rat mammary tumo
99 e usefulness of this new mouse model in lung cancer chemoprevention was examined.
100 hat addressed patient decisions about breast cancer chemoprevention, were published in 1995 or later,
101                           The future of lung cancer chemoprevention will rely heavily on molecular st
102 1 inhibition may be a promising strategy for cancer chemoprevention with lack of the adverse cardiova
103 identify women who might benefit from breast-cancer chemoprevention with tamoxifen or be suitable for
104 how the feasibility of targeting mPGES-1 for cancer chemoprevention with the potential for improved t
105                         A novel approach for cancer chemoprevention would involve LOX modulators, i.e

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top